{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:11:30Z","timestamp":1788462690949,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":231,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["140290\/2019-2"],"award-info":[{"award-number":["140290\/2019-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304450\/2019-7"],"award-info":[{"award-number":["304450\/2019-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["420695\/2018-4"],"award-info":[{"award-number":["420695\/2018-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["17\/2551-0000977-0"],"award-info":[{"award-number":["17\/2551-0000977-0"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007395","name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Excitotoxicidade e Neuroprote\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.pnpbp.2022.110602","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T18:45:33Z","timestamp":1657997133000},"page":"110602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Modulation of adenosine signaling reverses 3-nitropropionic acid-induced bradykinesia and memory impairment in adult zebrafish"],"prefix":"10.1016","volume":"119","author":[{"given":"Melissa Talita","family":"Wiprich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefani","family":"Altenhofen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlan","family":"Gusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela da Rosa","family":"Vasques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Zanandrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Wilges","family":"Kist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Reis","family":"Bogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Denise","family":"Bonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2022.110602_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12031-018-1062-x","article-title":"Sertoli cells avert neuroinflammation-induced cell death and improve motor function and striatal atrophy in rat model of Huntington disease","volume":"65","author":"Ahmadi","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00702-015-1390-8","article-title":"Benzodiazepines alter nucleotide and nucleoside hydrolysis in zebrafish (Danio rerio) brain","volume":"122","author":"Altenhofen","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.aquatox.2016.11.013","article-title":"Manganese(II) chloride alters behavioral and neurochemical parameters in larvae and adult zebrafish","volume":"182","author":"Altenhofen","year":"2017","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0025","first-page":"57","article-title":"Targeting adenosine receptors in neurological diseases","volume":"23","author":"Atif","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/nmt-2016-0008","article-title":"The global prevalence of Huntington\u2019s disease: a systematic review and discussion","volume":"6","author":"Baig","year":"2016","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ncl.2020.01.004","article-title":"Treatment of tardive dyskinesia","volume":"38","author":"Bashir","year":"2020","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2009.07.001","article-title":"A one-trial inhibitory avoidance task to zebrafish: rapid acquisition of an NMDA-dependent long-term memory","volume":"92","author":"Blank","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0050","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1523\/JNEUROSCI.22-20-09122.2002","article-title":"The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity","volume":"22","author":"Blum","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0055","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","article-title":"A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists","volume":"23","author":"Blum","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fnins.2020.00082","article-title":"Cortical and striatal circuits in Huntington\u2019s disease","volume":"14","author":"Blumenstock","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gep.2008.11.006","article-title":"Identification of zebrafish A2 adenosine receptors and expression in developing embryos","volume":"9","author":"Boehmer","year":"2009","journal-title":"Gene Expr."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5698\/1535-7511-13.1.35","article-title":"Adenosine and seizure termination: endogenous mechanisms","volume":"13","author":"Boison","year":"2013","journal-title":"Epilepsy. Curr."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114321","article-title":"Adenosine kinase: a key regulator of purinergic physiology","volume":"187","author":"Boison","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1385-299X(96)00037-2","article-title":"Hyperactivity and hypoactivity in a rat model of Huntington\u2019s disease: the systemic 3-nitropropionic acid model","volume":"1","author":"Borlongan","year":"1997","journal-title":"Brain. Res. Brain. Res. Protoc."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0085","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11011-017-0086-1","article-title":"Selective A2A receptor antagonist SCH 58261 modulates striatal oxidative stress and alleviates toxicity induced by 3-Nitropropionic acid in male Wistar rats","volume":"32","author":"Bortolatto","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nlm.2014.11.016","article-title":"Modulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish","volume":"118","author":"Bortolotto","year":"2015","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0095","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","article-title":"Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat","volume":"70","author":"Brouillet","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington\u2019s disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0105","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0110","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4103\/1673-5374.165300","article-title":"Purinergic signalling in neuroregeneration","volume":"10","author":"Burnstock","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nmeth.2697","article-title":"The need for transparency and good practices in the qPCR literature","volume":"10","author":"Bustin","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0125","doi-asserted-by":"crossref","first-page":"46741","DOI":"10.1074\/jbc.M306451200","article-title":"Adenosine A2A-dopamine D2 receptor-receptor heterodimerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer","volume":"278","author":"Canals","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0130","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10072-019-04177-8","article-title":"Late-onset Huntington\u2019s disease with 40\u201342 CAG expansion","volume":"41","author":"Capiluppi","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ntt.2011.08.010","article-title":"Early exposure to caffeine affects gene expression of adenosine receptors, DARPP-32 and BDNF without affecting sensibility and morphology of developing zebrafish (Danio rerio)","volume":"l33","author":"Capiotti","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0140","first-page":"981","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.genrep.2018.03.001","article-title":"Insights into the aquaporin 4 of zebrafish (Danio rerio) through evolutionary analysis, molecular modeling and structural dynamics","volume":"11","author":"Chakraborty","year":"2018","journal-title":"Gene. Rep."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0150","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","article-title":"Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington\u2019s disease","volume":"11","author":"Chan","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40478-021-01213-7","article-title":"Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy","volume":"9","author":"Chang","year":"2021","journal-title":"Acta. Neuropathol. Commun."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-801022-8.00012-X","article-title":"Adenosine receptor control of cognition in normal and disease","volume":"119","author":"Chen","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0165","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","article-title":"cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant huntingtin with expanded polyglutamine residues","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuropharm.2015.04.001","article-title":"Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands","volume":"98","author":"Ciruela","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0180","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1080\/14656566.2019.1674281","article-title":"Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington\u2019s disease: a review of clinical trial data","volume":"20","author":"Claassen","year":"2019","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbr.2010.03.003","article-title":"Interactions between adenosine and dopamine recpetor antagonists with different selectivity profiles: effects on locomotor activity","volume":"211","author":"Collins","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0190","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/molecules25030482","article-title":"Huntington\u2019s disease: a review of the known PET imaging biomarkers and targeting radiotracers","volume":"25","author":"Cybulska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington\u2019s disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2014.08.013","article-title":"Expression, pharmacoloy and functional activity of adenosine A1 receptors in genetic models of Huntington\u2019s disease","volume":"71","author":"Ferrante","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/caff.2019.0008","article-title":"Functional and neuroprotective role of striatal adenosine A2A receptor heterotetramers","volume":"9","author":"Ferr\u00e9","year":"2019","journal-title":"J. Caffeine. Adenosine."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199412300-00020","article-title":"Postsynaptic antagonist interaction between adenosine A1 and dopamine D1 receptors","volume":"6","author":"Ferr\u00e9","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1100\/tsw.2007.211","article-title":"Adenosine receptor heteromers and their integrative role in striatal function","volume":"7","author":"Ferr\u00e9","year":"2007","journal-title":"Sci. World J."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0220","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","article-title":"Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage","volume":"88","author":"Fink","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0225","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0230","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1755-5949.2009.00126.x","article-title":"Adenosine-dopamine interactions in the pathophysioloy and treatment of CNS disorders","volume":"16","author":"Fuxe","year":"2010","journal-title":"CNS. Neurosci. Ther."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0091-3057(00)00422-6","article-title":"Drinks like a fish: Zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects","volume":"67","author":"Gerlai","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112264","article-title":"Tryptophan alleviates neuroendocrine and behavioral responses to stress in zebrafish","volume":"378","author":"Giacomini","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0245","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in human basal ganglia in Huntington\u2019s disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0250","doi-asserted-by":"crossref","first-page":"R509","DOI":"10.1016\/S0960-9822(00)00593-5","article-title":"The basal ganglia","volume":"l10","author":"Graybiel","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0255","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11302-019-09667-0","article-title":"Adenosine receptor expression in the adult zebrafish retina","volume":"15","author":"Grillo","year":"2019","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0260","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington\u2019s disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2016.08.013","article-title":"Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease","volume":"96","author":"Guitart","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fnbeh.2020.00103","article-title":"Pyriproxyfen exposure impairs cognitive parameters and alters cortisol levels in zebrafish","volume":"14","author":"Gusso","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-013-3158-x","article-title":"Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex","volume":"230","author":"Horita","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0280","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/14656566.2019.1614167","article-title":"Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson\u2019s disease: a single-arm, open-label, prospective, multicenter study","volume":"20","author":"Iijima","year":"2019","journal-title":"Expet. Opin. Pharmacother."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0285","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1134\/S0006297918090043","article-title":"Molecular pathogenesis in Huntington\u2019s disease","volume":"83","author":"Illarioshkin","year":"2018","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0290","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/nu13030803","article-title":"Methylxanthines and neurodegenerative diseases: an update","volume":"13","author":"Janitschke","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0295","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.parkreldis.2020.09.026","article-title":"Can adenosine A2A receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson\u2019s disease?","volume":"80","author":"Kanda","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0300","first-page":"467","article-title":"Targeting ENT1 and adenosine tone for the treatment of Huntington\u2019s disease","volume":"26","author":"Kao","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0305","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.toxrep.2015.08.004","article-title":"Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats","volume":"2","author":"Kaur","year":"2015","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0310","first-page":"24","article-title":"Use of zebrafish genetic models to study etiology of the amyloid-beta and neurofibrillary tangle pathways in Alzheimer\u2019s disease","author":"Kiper","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0315","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jnr.24495","article-title":"Dysfunctional striatal dopamine signaling in Huntington\u2019s disease","volume":"97","author":"Koch","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnmol.2016.00055","article-title":"Function over form: modeling groups of inherited neurological conditions in zebrafish","volume":"9","author":"Kozol","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: release mechanisms and extracellular concentrations","volume":"79","author":"Latini","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0330","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1007\/s12035-018-1030-z","article-title":"Adenosine augmentation evoked by an ENT1 inhibitor improves memory impairment and neuronal plasticity in the APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0335","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","article-title":"Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington\u2019s disease models","volume":"79","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JHD-170241","article-title":"Safety and exploratory efficacy at 36 months in open-HART, and open-label extension study of pridopidine in Huntington\u2019s disease","volume":"6","author":"McGarry","year":"2017","journal-title":"J. Huntingtons. Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0345","first-page":"29","article-title":"A2A adenosine receptor antagonists in neurodegenerative diseases","author":"Merighi","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0350","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.pharep.2014.07.006","article-title":"Improvement of mitochondrial NAD(+)\/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease","volume":"66","author":"Mishra","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0355","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pnpbp.2019.03.014","article-title":"Withdrawal effects following repeated ethanol exposure are prevented by N-acetylcysteine in zebrafish","volume":"93","author":"Mocelin","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0360","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-5793(90)80638-Y","article-title":"Characterization of the locomotor depression produced by an A2A selective agonist","volume":"261","author":"Nikodijevic","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0365","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/mdc3.13148","article-title":"Disease onset in Huntington\u2019s disease: when is the conversion?","volume":"8","author":"Oosterloo","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0370","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1111\/bph.13180","article-title":"Adenosine a(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice","volume":"172","author":"Pagnussat","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0375","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1358\/dot.2020.56.2.3098156","article-title":"Istradefylline: adenosine A2A receptor antagonist to reduce \u201cOFF\u201d time in Parkinson\u2019s disease","volume":"56","author":"Paton","year":"2020","journal-title":"Drugs. Today (Barc)."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0380","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(02)01307-9","article-title":"Blockade of adenosine A1 receptors in the posterior cingulate cortex facilitates memory in rats","volume":"437","author":"Pereira","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2020.108936","article-title":"Antibiotic drugs alter zebrafish behavior","volume":"242","author":"Petersen","year":"2021","journal-title":"Comp. Biochem. Physiol. C. Toxicol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0390","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaff","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0395","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington\u2019s disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.655550","article-title":"The promise of the zebrafish model for Parkinson\u2019s disease: today\u2019s science and tomorrow\u2019s treatment","volume":"12","author":"Razali","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0405","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2015.11.006","article-title":"Purine nucleosides in neuroregeneration and neuroprotection","volume":"104","author":"Ribeiro","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0410","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","article-title":"Lessons from animal models of Huntington\u2019s disease","volume":"18","author":"Rubinsztein","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0415","doi-asserted-by":"crossref","first-page":"193","DOI":"10.14802\/jmd.21035","article-title":"Emerging nondopaminergic medications for Parkinson\u2019s disease: focusing on A2A receptor antagonists and GLP1 receptor agonists","volume":"14","author":"Shang","year":"2021","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0420","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1523\/JNEUROSCI.5255-07.2008","article-title":"A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs","volume":"28","author":"Shen","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0425","article-title":"Adenosine A2A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation","volume":"28","author":"Shen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0430","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/zeb.2014.1004","article-title":"Role of adenosine signaling on pentylenetetrazole-induced seizures in zebrafish","volume":"12","author":"Siebel","year":"2015","journal-title":"Zebrafish"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0435","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ncl.2020.01.010","article-title":"Medical, surgical, and genetic treatment of Huntington disease","volume":"38","author":"Stahl","year":"2020","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22040676","article-title":"Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration","volume":"22","author":"Stockwell","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0445","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insight into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0450","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1745-7270.2007.00283.x","article-title":"Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization","volume":"39","author":"Tang","year":"2007","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0455","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1353-8020(98)00007-8","article-title":"Dipyridamole potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced experimental parkinsonism in mice","volume":"4","author":"Tariq","year":"1998","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0465","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","article-title":"Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors","volume":"25","author":"Temido-Ferreira","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0470","first-page":"971","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Huntingt. Dis. Collab. Res. Group Cell"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0475","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxicon.2020.05.012","article-title":"The effect of 3-nitropropionic acid on behavioral dysfunction, neuron loss and gliosis in the brain of adult male rats: the case of prefrontal cortex, hippocampus and the cerebellum","volume":"183","author":"Torabi","year":"2020","journal-title":"Toxicon."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0480","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbr.2015.10.061","article-title":"Interaction between handling induced stress and anxiolytic effects of ethanol in zebrafish: a behavioral and neurochemical analysis","volume":"298","author":"Tran","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0485","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the machanims involved in Huntington\u2019s disease: past, present and future","volume":"15","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0490","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2014.11.004","article-title":"Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington\u2019s disease","volume":"74","author":"Tyebji","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0495","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","article-title":"Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington\u2019s disease","volume":"15","author":"Villar-Men\u00e9ndez","year":"2013","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0500","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(93)90522-J","article-title":"Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory","volume":"249","author":"Von Lubitz","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0505","series-title":"The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio)","author":"Westerfield","year":"2000"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2020.108772","article-title":"Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults","volume":"234","author":"Wiprich","year":"2020","journal-title":"Comp. Biochem. Physiol. C. Toxicol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0515","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2015.10.031","article-title":"Purinergic receptors as potential therapeutic targets in Alzheimer disease","volume":"104","author":"Woods","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2022.110602_bb0520","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/cne.23525","article-title":"Ancestry of basal ganglia circuits: new evidence in teleosts","volume":"522","author":"Wullimann","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pnpbp.2022.110602_bb0525","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1007\/s12035-020-01970-x","article-title":"Withdrawal effects following methionine exposure in adult zebrafish","volume":"57","author":"Zanandrea","year":"2020","journal-title":"Mol. Neurobiol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462200094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462200094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:01:35Z","timestamp":1759521695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462200094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":105,"alternative-id":["S027858462200094X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110602","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of adenosine signaling reverses 3-nitropropionic acid-induced bradykinesia and memory impairment in adult zebrafish","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110602"}}